Company: SLDE
Filing Date: 2025-06-18
Form Type: 424B4
Source: 0001193125-25-142810
Chunk: 180

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-06-18
Form: 424B4
Chunk 180
---
 — |     |        |   245,366 |     |              | 16,003 |     |           |  1,529,638 |
| Shannon Lucas (5)                            |     |      | 2024 |     |            | 674,160 |     |              | 10,000,000 |     |               | 5,852,000 |     |        |         — |     |              | 16,233 |     |           | 16,542,393 |
| Chief Operating Officer & Chief Risk Officer |     |      | 2023 |     |            | 636,000 |     |              |  1,500,000 |     |               |         — |     |        |   704,095 |     |              | 15,633 |     |           |  2,855,728 |

| (1) | This column reflects annual discretionary bonuses received in respect of 2023 and 2024 services. |

| (2) | This column reflects the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of the                                                                                                                                            
 restricted stock units that settle in shares of our common stock granted to the named executive officers, which is measured on the grant date based on the fair market value of our common stock. For a further discussion of the assumptions used in the 
 calculation of the grant-date fair values for the restricted stock units pursuant to ASC 718, see Note 23 Stock-based Compensation to our financial statements included elsewhere in this prospectus. For further discussion of grants made in 2024,      
 see “ —Outstanding Equity Awards at Fiscal Year End” table.                                                                                                                                                                                               |

| (3) | This column reflects the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of the                                                                                                                                          
 options to purchase shares of our common stock granted to the named executive officers, which is measured on the grant date based on the fair market value of our common stock, excluding the effect of estimated forfeitures, assuming all performance 
 goals are achieved with respect to the performance-based options (which was the probable outcome of the related performance conditions as of their grant date). For a further discussion of the assumptions used in the calculation of the grant-date   
 fair values for the stock options pursuant to ASC 718, see Note 23 Stock-based Compensation to our financial statements included elsewhere in this prospectus. For further discussion of outstanding option grant, see “—Outstanding Equity             
 Awards